BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8657419)

  • 21. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
    Conner P; Skoog L; Söderqvist G
    Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postmenopausal hormone therapy and the risk of breast cancer: a contrary thought.
    Speroff L
    Menopause; 2008; 15(2):393-400. PubMed ID: 17925662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and breast cancer: what is the problem?
    Kenemans P
    Maturitas; 2005 May; 51(1):75-82. PubMed ID: 15883112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML; van de Weijer P; Franke HR; Pornel B; von Mauw EM; Nijland EA;
    BJOG; 2007 Dec; 114(12):1522-9. PubMed ID: 17995496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
    van de Weijer PH; Mattsson LA; Ylikorkala O
    Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
    Neven P; Lunde T; Benedetti-Panici P; Tiitinen A; Marinescu B; de Villiers T; Hillard T; Cano A; Peer E; Quail D; Nickelsen T;
    BJOG; 2003 Feb; 110(2):157-67. PubMed ID: 12618160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Neves-E-Castro M
    Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Estrogens following menopause. Methods of hormone replacement].
    Robyn C
    Rev Med Brux; 1995; 16(4):291-4. PubMed ID: 7481245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormone substitution beginning when, with what, how long?].
    Breckwoldt M; Keck C
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):M67-9. PubMed ID: 8050681
    [No Abstract]   [Full Text] [Related]  

  • 35. Improving continuation rates for hormone replacement therapy.
    Gambrell RD
    Menopause; 2002; 9(1):3-5. PubMed ID: 11791080
    [No Abstract]   [Full Text] [Related]  

  • 36. [General prevention of osteoporosis--yes or no?].
    Göretzlehner G
    Zentralbl Gynakol; 1990; 112(14):865-6. PubMed ID: 2264405
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gestagens and hormone substitution].
    Klinger G
    Zentralbl Gynakol; 1995; 117 Suppl():25-9. PubMed ID: 8571690
    [No Abstract]   [Full Text] [Related]  

  • 38. Postmenopausal hormone therapy.
    Thacker HL; Booher D
    Ann Intern Med; 1993 Aug; 119(4):347; author reply 347-8. PubMed ID: 8328755
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of progestins].
    Wyss HI
    Arch Gynecol Obstet; 1989; 246 Suppl():S85-91. PubMed ID: 2686564
    [No Abstract]   [Full Text] [Related]  

  • 40. Postmenopausal hormone therapy.
    Steel K
    Ann Intern Med; 1993 Aug; 119(4):347; author reply 347-8. PubMed ID: 8328754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.